Fundraising Fox
/Companies
Sign in

Carmine Therapeutics

Cambridge, US · Founded 2021 · Delaware corporation · 6 employees on LinkedIn

Find your way into Carmine Therapeutics

Sign up to see every warm intro you have to Carmine Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Carmine Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Carmine Therapeutics develops gene therapies using non-viral gene transfer vector systems based on extracellular vesicle technology. The company works on delivering genetic medicines and is affiliated with academic research from institutions including MIT and the National University of Singapore.

BiotechDeep TechHealthtech

Founders & leadership

Carmine Therapeutics was founded in 2021 by Minh Le and Tenzin.

MLMinh Le
Minh LeFounding scientist / Assistant ProfessorMinh Le holds a Ph.D. in Computational and Systems Biology from the Singapore-MIT Alliance and has conducted postdoctoral research on microRNAs at Harvard Medical School. He served as an assistant professor at City University of Hong Kong from 2015 to 2019 and joined the National University of Singapore as an assistant professor in Pharmacology in 2019, where he was promoted to Associate Professor with tenure in 2025; he is co-founder and founding scientist of Carmine Therapeutics.
T
TenzinFounding member; Associate at EVX Ventures
HLHarvey Lodish
Harvey LodishNamed on SEC filing
LX
Lin XiangqianNamed on SEC filing
DH
Donald HautNamed on SEC filing
EEElan Ezickson
Elan EzicksonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$13.7M disclosed across 1 round · 2022

▶$13.7MraisedNov 2022 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Harvey LodishDirector
  • Lin XiangqianDirector
  • Donald HautExecutive Officer, Director
  • Elan EzicksonDirector
Offering amount
$13.7M
Amount sold
$13.7M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

LifeMine TherapeuticsLifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Carmine Therapeutics.

In the news

Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy Collaboration - BioSpacebiospace.com · Jun 2020Carmine Therapeutics & Takeda Collaborate to Develop Novel Non-viral Gene Therapiescarminetherapeutics.com · Jun 2020EVX Ventures Announces the Launch of Carmine Therapeuticscarminetherapeutics.com · Aug 2019

Frequently asked questions

What does Carmine Therapeutics do?
Carmine Therapeutics develops gene therapies using non-viral gene transfer vector systems based on extracellular vesicle technology. The company works on delivering genetic medicines and is affiliated with academic research from institutions including MIT and the National University of Singapore.
Who founded Carmine Therapeutics?
Carmine Therapeutics was founded by Minh Le, Tenzin in 2021.
How much funding has Carmine Therapeutics raised?
Carmine Therapeutics has disclosed $13.7M raised across 1 round.
Where is Carmine Therapeutics headquartered?
Carmine Therapeutics is headquartered in Cambridge, US.